Company: PTHS
Filing Date: 2025-03-03
Form Type: 8-K
Source: 0001753926-25-000376
Chunk: 1

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-03
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item
9.01. Financial Statements and Exhibits

(c)
Exhibits:

  Exhibit      Description                                           
      No.                                                            
     10.1      Promissory Note dated February 25, 2025               
 ─────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive                                

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  Date: March 3, 2025      Channel Therapeutics Corporation                                                                                    
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                           By:                                   /s/                                                                           
                                                                 Name:                    Francis Knuettel II                                  
                                                                 Title:                   Chief Executive Officer and Chief Financial Officer